BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 35806168)

  • 1. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
    Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
    Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
    Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
    BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
    Zhang B; Jiang H; Dong Z; Sun A; Ge J
    Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of m6A modification in the biological functions and diseases.
    Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
    Petri BJ; Klinge CM
    J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
    Zou Y; Jiang G; Xie Y; Li H
    Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA m6A modification, signals for degradation or stabilisation?
    Wei G
    Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
    Zhang D; Zhang D; Wang C; Yang X; Zhang R; Li Q; Xiong Y
    Eur J Cancer Prev; 2022 Jul; 31(4):354-362. PubMed ID: 34519693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
    Chang H; Yang J; Wang Q; Zhao J; Zhu R
    Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of N6-Methyladenosine Modification in Tumors.
    Zhang N; Zuo Y; Peng Y; Zuo L
    J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
    Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
    Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA m6A methylation regulators in sepsis.
    Zhu L; Zhang H; Zhang X; Xia L
    Mol Cell Biochem; 2023 Sep; ():. PubMed ID: 37659034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.